Acquisition of medpex successfully concluded

Frankfurt, 7 January 2019. The Zur Rose Group has successfully completed the acquisition of the e-commerce activities of Germany’s third-largest online pharmacy medpex.

In the course of this transaction, the Group acquired Comventure GmbH in Forst (Germany), Visionrunner GmbH in Mannheim (Germany), medpex wholesale GmbH in Ludwigshafen (Germany), as well as Apotheke esando B.V. in Venlo (Netherlands). With this step, the Zur Rose Group is significantly expanding its market leadership in Germany.

ACXIT Capital Partners acted as Exclusive Financial Advisor to medpex and the selling shareholders.

About medpex

medpex was established in 2005 and is the third biggest mail-order pharmacy in Germany with more than three million customers. The core competencies in the areas of IT (tech platform) and online marketing, as well as the high profile among younger target groups have played a key role in contributing to the rapid growth of the Group. medpex is characterized by a strong customer focus and efficient processes – thus, in the business year 2017 only, the Group processed around 3.5 million purchase orders and acquired around 800,000 new customers. The company concentrates on over-the-counter drugs (OTC) and cosmetics exclusively supplied through pharmacies (BPC). medpex employs approximately 300 employees in total and generated revenues of EUR 139 million in 2017*. The Company based in Ludwigshafen owns Comventure GmbH (software and IT), Visionrunner GmbH (marketing), medpex wholesale GmbH (wholesale and logistics), and Apotheke esando B.V. based in the Netherlands.

About Zur Rose Group

The Swiss-based Zur Rose Group is Europe’s biggest mail-order pharmacy and one of Switzerland’s leading wholesale suppliers to medical practitioners. The business model enables the Group to offer high-quality, safe and cost-effective pharmaceutical care. The Group also excels at continually developing digital services in the area of medicines management to increase therapeutic safety and it has also become established as an important strategic partner for healthcare providers, payers and industry.
The Zur Rose Group has an international profile with strong brands, including Germany’s most familiar pharmacy brand DocMorris. The Company employs more than 1,000 employees at various locations and generated revenues of CHF 983 million in the business year 2017.

About ACXIT Capital Partners

ACXIT Capital Partners is a leading international corporate finance and investment advisory firm for mid-market clients and entrepreneurs in Europe and beyond. Since 1998, ACXIT offers its clients comprehensive corporate finance advisory services including M&A and capital markets advisory as well as restructuring, equity/debt and strategic advisory. As an independent, privately owned firm we maintain offices in Frankfurt, Berlin, Munich, Leipzig and Zurich, representatives in Hong Kong and the US as well as strong alliances in France, China and India. (

ACXIT Capital Holding GmbH
Bockenheimer Landstraße 24
60323 Frankfurt am Main
Dr. Hartmut Vennen
Senior Managing Director, Strategic Communications
FTI Consulting
Park Tower | Bockenheimer Anlage 44
60322 Frankfurt am Main
Phone: +49 69 92037 137
Mobile: +49 160 895 5858


Johannes H. Lucas, Managing Partner
Klaus Nestler, Managing Director
Sebastian Engelbrecht, Analyst
Benedikt Gentner, Analyst

*Revenues (in accordance with German HGB) generated by Stifts-Apotheke e.K. in 2017. Proprietor: Christiane Bülow-Bichler – medpex Versandapotheke –, Ludwigshafen am Rhein